These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Lee J; Torosyan N; Silverman DH Exp Gerontol; 2017 Jan; 87(Pt A):121-128. PubMed ID: 27856335 [TBL] [Abstract][Full Text] [Related]
29. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Malouf R; Grimley Evans J Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658 [TBL] [Abstract][Full Text] [Related]
30. Effect of long-term nutraceutical and dietary supplement use on cognition in the elderly: a 10-year systematic review of randomised controlled trials. D'Cunha NM; Georgousopoulou EN; Dadigamuwage L; Kellett J; Panagiotakos DB; Thomas J; McKune AJ; Mellor DD; Naumovski N Br J Nutr; 2018 Feb; 119(3):280-298. PubMed ID: 29310724 [TBL] [Abstract][Full Text] [Related]
31. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351 [TBL] [Abstract][Full Text] [Related]
32. Effects of a Six-Month Multi-Ingredient Nutrition Supplement Intervention of Omega-3 Polyunsaturated Fatty Acids, vitamin D, Resveratrol, and Whey Protein on Cognitive Function in Older Adults: A Randomised, Double-Blind, Controlled Trial. Moran C; Scotto di Palumbo A; Bramham J; Moran A; Rooney B; De Vito G; Egan B J Prev Alzheimers Dis; 2018; 5(3):175-183. PubMed ID: 29972210 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
34. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. De Jesus Moreno Moreno M Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial. Fujino T; Yamada T; Asada T; Tsuboi Y; Wakana C; Mawatari S; Kono S EBioMedicine; 2017 Mar; 17():199-205. PubMed ID: 28259590 [TBL] [Abstract][Full Text] [Related]
36. Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study. Shiojima Y; Takahashi M; Takahashi R; Moriyama H; Bagchi D; Bagchi M; Akanuma M J Am Nutr Assoc; 2022; 41(8):796-809. PubMed ID: 34415830 [TBL] [Abstract][Full Text] [Related]